PT-141, derived from Melanotan II, was specifically developed to enhance sexual arousal and is now FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women
The bilayer is composed of 82.05% Phosphatidylcholine (PC) and 10.82% Phosphatidylethanolamine (PE), yielding a total phospholipid content of 93%, with over 75% forming uniform, high-integrity liposomal structures
Per established liability guidance, the worst outcome in a board investigation is a patient who says the physician never even told me this wasnt approved. For long-term prescribing, re-obtain and re-document consent as the evidence base and regulatory status evolve, particularly if FDA acts on the PCAC recommendation and the compounds legal status changes
Through advocacy, program development, and education, we're fighting for them all
Doctors describe this as a unique situation whereby so many brands of the same medicine are set to be launched on the same day